• Facebook
  • Twitter
  • Youtube
  • Instagram
  • LinkedIn
  • Rss
  • Store
  • Donate
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • The 1986 Club
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2022 State of Cancer Survivorship Survey
    • 2021 State of Cancer Survivorship Survey
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • 2022 Winners
      • Awardees
      • Sponsors
      • Committees
    • Cancer Policy Roundtable (CPR)
      • Fall 2022 CPR
      • Spring 2022 CPR
      • Fall 2021 CPR
      • Spring 2021 CPR
      • Fall 2020 CPR
      • Spring 2020 CPR
    • Cancer Policy and Advocacy Team (CPAT) Virtual Symposium 2022
    • 2022 State of Survivorship Survey Results
    • Webinars
  • Contact Us
  • Search
  • Menu Menu
  • 0Shopping Cart

Your generous year-end donation will be matched $1 for $1    DONATE

NCCS Starburst 250px

WCOE: HHS Hints at Lax ACA Regulation; Burden of High Drug Costs; FDA’s Gottlieb Blasts ‘Rigged Payment Scheme’; Home BRCA Testing; More

March 9, 2018/in Cancer News, Cancer Policy Blog Access to Care, Affordable Care Act, Drug Pricing, Financial Toxicity, Health Equity NCCS News /by actualize
What Caught Our Eye (WCOE), March 9, 2018
What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention.

Affordable Care Act

“Trump Administration Blocks Idaho’s Plan to Circumvent Health Law”

The Trump administration rejected Idaho’s plan to allow the sale of stripped-down, low-cost health insurance that violates the Affordable Care Act https://t.co/28FmVbHwyD

— NYT Politics (@nytpolitics) March 9, 2018

New York Times — While rejecting Idaho’s plan in its current form, Ms. Verma encouraged the state to keep trying, and she suggested that, “with certain modifications,” its proposal might be accepted.
Read More »

“Azar hints ACA health plans could see laxer regulation”

HHS @SecAzar told a crowd of insurers on Thursday that the Trump administration will do what it can "within the law" to let insurers offer plans that go beyond what is allowed under the Affordable Care Act. https://t.co/yio3J2HpkP pic.twitter.com/amzh44Vqak

— Modern Healthcare (@modrnhealthcr) March 9, 2018

Modern HealthCare — HHS Secretary Alex Azar told a crowd of insurers on Thursday that the Trump administration will do what it can “within the law” to let insurers offer plans that go beyond what is allowed under the Affordable Care Act.
Read More »

“A Connecticut proposal could charge up to $10,000 for not carrying health insurance”

https://twitter.com/sarahkliff/status/971755689516429313

Vox.com — Connecticut is considering a proposal to create a super-charged individual mandate — one that could charge state residents a big chunk of their income for not carrying coverage.
Read More »


Coping With Cancer

“The Price They Pay”

After reading this I don't want to argue about health care policy – I want to remind everyone we have a moral obligation to care for each other, regardless of where you believe that obligation comes from. We are failing. Thanks @katie_thomas @NormOrnstein https://t.co/inR7izFANZ

— Mitchell "the virus isn't done with us yet" Stein (@mhstein) March 5, 2018

New York Times — The burden of high drug costs weighs most heavily on the sickest Americans.

Drug makers have raised prices on treatments for life-threatening or chronic conditions like multiple sclerosis, diabetes and cancer. In turn, insurers have shifted more of those costs onto consumers. Saddled with high deductibles and other out-of-pocket costs that expose them to a drug’s rising list price, many people are paying thousands of dollars a month merely to survive.
Read More »

“Symptom Burden Highest 1 Month After Cancer Dx”

Nice study @JCO_ASCO on symptoms in pts with new dx of cancer. Honored to provide comment. @RIHospital Symptom Burden Highest 1 Month After Cancer Dx https://t.co/eZslt1J3Bj

— Don S. Dizon MD 🇬🇺 (@drdonsdizon) March 8, 2018

Med Page Today — Most cancer patients experience clinically significant symptoms in the first year after diagnosis and require tailored supportive care, according to a retrospective observational study of over 120,000 patients in Canada.

The analysis of patient-reported outcomes (PROs) showed that moderate-to-severe symptoms affected “well-being” in 55% of patients with all cancer types, particularly in the first month after diagnosis.
Read More »


Cancer News

“FDA commissioner to health insurers: You’re doing it wrong”

FDA Commissioner Scott Gottlieb critiqued drug rebates at AHIP's National Health Policy Conference. https://t.co/ZRBLv0EtTW

— MedPage Today (@medpagetoday) March 9, 2018

CNBC.com — Insurance is designed, theoretically, to protect against the catastrophic: tornadoes, floods, hurricanes — or, where our health is concerned, cancer or another devastating disease.To make that financial protection affordable, many pay into the system: the healthy are supposed to subsidize the sick. But at a conference Wednesday organized by the health insurance industry, FDA Commissioner Scott Gottlieb delivered a startling message: You’re doing it wrong.
Read More »

“Vinay Prasad on the NCCN’s cancer treatment guidelines: The US system needs an audit”

https://twitter.com/VinayPrasad82/status/971530016600211456

BMJ Opinion — What level of evidence should we have before costly, toxic cancer drugs are given to patients?
Read More »

“FDA approves first direct-to-consumer test for breast cancer risk”

JUST IN: @US_FDA approves the first direct-to-consumer test for breast/ovarian cancer genes, but with cautions. https://t.co/bg9QqCfoBk

— STAT (@statnews) March 6, 2018

STAT News — Federal regulators approved the first direct-to-consumer test for the BRCA genes, which increase the risk of breast and ovarian cancer.
Read More »

“All Cancer Patients Should Have Access To Genomic Testing”

"Without access to these tests, those whose cancers have mutations for which matched, precision oncology drugs are available are doomed to take old-style chemotherapy before they might even consider new options." @ESchattner #bcsm https://t.co/u527vtqqyJ

— Susan G. Komen NYC (@KomenGreaterNYC) March 9, 2018

Forbes.com — The novelty of Foundation’s approach—like that of a few other companies leading the field of cancer diagnostics—is the scope of testing. These laboratories examine hundreds of genes by a method called next-generation sequencing (NGS). For a price of $5800, in two weeks’ time, Foundation reports on tumor mutation burden (TMB), microsatellite instability (MSI), and mutations in any of 324 genes that may indicate sensitivity—or resistance—to oncology drugs.
Read More »

“Race/Ethnicity and Age Distribution of Breast Cancer Diagnosis in the United States”

#Breastcancer screening redefined by taking race into account https://t.co/BinlVvvCvF pic.twitter.com/RkBDxg7XCs

— JAMA Surgery (@JAMASurgery) March 9, 2018

JAMA Surgery — The US Preventive Services Task Force (USPSTF) currently recommends initiating breast cancer screening at 50 years of age in patients at average risk.1 However, we hypothesize that these guidelines may not be sensitive to racial differences and may be inappropriately extrapolating data from largely white populations for use in racially diverse populations. This process could result in underscreening of nonwhite female patients.
Read More »


More From “What Caught Our Eye” »

Follow us on Twitter: @CancerAdvocacy


Tags: affordable care act, cancer care, Cancer Survivorship, drug pricing, FDA, financial issues, What Caught Our Eye
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
https://canceradvocacy.org/wp-content/uploads/2017/01/NCCS-Starburst-250px.png 250 250 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2018-03-09 17:40:262018-03-09 17:40:26WCOE: HHS Hints at Lax ACA Regulation; Burden of High Drug Costs; FDA’s Gottlieb Blasts ‘Rigged Payment Scheme’; Home BRCA Testing; More

Latest News

NCCS Advocate Spotlight: Sharon Rivera Sanchez - Triple Negative Breast Cancer Survivor Finds Passion in Fitness and Advocacy

Sharon Rivera-Sanchez: Triple Negative Breast Cancer Survivor Finds Passion in Fitness and Advocacy

January 12, 2023
As a Triple Negative Breast Cancer survivor, Sharon turned her personal experience into a passion for advocacy and giving back to the community. When she received her diagnosis in May 2015, she remembers being in a state of shock and grief. She said, “You have to allow yourself time to breathe and grieve.”
Read more
https://canceradvocacy.org/wp-content/uploads/Advocate-Spotlight-Sharon-Rivera-Sanchez.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2023-01-12 15:24:442023-01-12 15:24:44Sharon Rivera-Sanchez: Triple Negative Breast Cancer Survivor Finds Passion in Fitness and Advocacy
Rep. Debbie Wasserman Schultz introduces Comprehensive Cancer Survivorship Act at December 14, 2022 press conference.

NCCS Celebrates Launch of Comprehensive Cancer Survivorship Act

December 14, 2022
Representative Debbie Wasserman Schultz (FL-23), a champion for cancer survivors and a survivor herself, held a press conference today…
Read more
https://canceradvocacy.org/wp-content/uploads/CCSA-Blog-Featured-Image-1200-×-600-px-1.png 600 1200 Kara Kenan https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png Kara Kenan2022-12-14 16:03:462022-12-14 16:03:46NCCS Celebrates Launch of Comprehensive Cancer Survivorship Act
Alique Topalian, PhD, MPH Advocate Spotlight

Alique Topalian: Childhood Cancer and the Frightening Realities of the Survivorship Journey

December 7, 2022
Alique was first diagnosed with Acute Myeloid Leukemia (AML) at the age of four. Her mother, Michele, knew something was wrong because “the light in her eyes was gone”. After being told by doctors that there was nothing wrong, her family was relentless until new blood work uncovered blast cells.
Read more
https://canceradvocacy.org/wp-content/uploads/Alique-Topalian-Advocate-Spotlight.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2022-12-07 11:46:562022-12-07 11:48:28Alique Topalian: Childhood Cancer and the Frightening Realities of the Survivorship Journey

Take Action

Make An Impact

We are relentless in improving the quality of care and life after a cancer diagnosis. Your support makes all the difference right now.

Make a Gift »

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • This field is for validation purposes and should be left unchanged.

  • About
    • Our Mission
    • Our History
    • The 1986 Club
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2022 State of Cancer Survivorship Survey
    • 2021 State of Cancer Survivorship Survey
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • 2022 Winners
      • Awardees
      • Sponsors
      • Committees
    • Cancer Policy Roundtable (CPR)
      • Fall 2022 CPR
      • Spring 2022 CPR
      • Fall 2021 CPR
      • Spring 2021 CPR
      • Fall 2020 CPR
      • Spring 2020 CPR
    • Cancer Policy and Advocacy Team (CPAT) Virtual Symposium 2022
    • 2022 State of Survivorship Survey Results
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2023 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

ACA Update March 9, 2018 | HHS Says ‘Not Quite’ to Idaho’s... ProtectOurCare 1024px Fotolia 23428619 S e1461260836640 NCCS Joins Cancer Leadership Council to Oppose the Latest Version of Right to...
Scroll to top
Download the Survey Report

"*" indicates required fields

Fill out the form below, and we’ll send the survey report, detailed presentation, and infographic to your email.
Name*
I am a...*
Select any/all that apply.
Consent*
By downloading the survey materials, you will receive updates and information from NCCS via email, which you may unsubscribe from at any time. Your information will never be sold to any third parties.
This field is for validation purposes and should be left unchanged.

Get Updates From NCCS

Be the first to hear about cancer policy and survivorship issues! Subscribe and receive the biweekly NCCS Health Care Roundup, invites to webinars and events, and more.

  • This field is for validation purposes and should be left unchanged.

Connect With Us

Twitter     Facebook     Instagram     LinkedIn     YouTube

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute